{"title":"Elevated renin activity and change in sleep apnea with primary aldosteronism","authors":"Yonekazu Kidawara, Manabu Kadoya, Masataka Igeta, Miki Kakutani-Hatayama, Akiko Morimoto, Akio Miyoshi, Akinori Kanzaki, Kosuke Konishi, Takashi Daimon, Hidenori Koyama","doi":"10.1101/2024.08.01.24311390","DOIUrl":null,"url":null,"abstract":"Background: The prevalence of obstructive sleep apnea (OSA) is higher in patients with primary aldosteronism (PA), while elevated renin activity after treatment is associated with a lower risk of cardiovascular events. However, the association of PA with degree of OSA remains unclear and it is not known whether elevated renin activity in PA patients is associated with change in apnea condition. Methods: Cross-sectional relationships between PA (n=176) and degree of OSA classified by apnea-hypopnea index (AHI) with use of an apnomonitor were investigated, with the results compared with those obtained with non-PA patients (n=418). Additionally, the effects of elevated renin activity on change in AHI were prospectively examined in 45 patients with PA.\nResults: Patients with PA were found to be significantly associated with severe OSA even after adjustment for other clinical risk factors (odds ratio 2.08, 95% confidence interval 1.09-3.95, p = 0.025) as compared to those without PA. Furthermore, the logarithm of the renin activity after treatment and change in AHI before and after treatment were significantly negatively correlated, with Pearson's correlation coefficient (r = -0.364, p = 0.014).\nConclusions: Severe OSA is more commonly seen in PA patients with hypertension as compared to patients without PA, and elevated renin activity may contribute to improvement of sleep apnea in patients with PA.","PeriodicalId":501419,"journal":{"name":"medRxiv - Endocrinology","volume":"25 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.08.01.24311390","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The prevalence of obstructive sleep apnea (OSA) is higher in patients with primary aldosteronism (PA), while elevated renin activity after treatment is associated with a lower risk of cardiovascular events. However, the association of PA with degree of OSA remains unclear and it is not known whether elevated renin activity in PA patients is associated with change in apnea condition. Methods: Cross-sectional relationships between PA (n=176) and degree of OSA classified by apnea-hypopnea index (AHI) with use of an apnomonitor were investigated, with the results compared with those obtained with non-PA patients (n=418). Additionally, the effects of elevated renin activity on change in AHI were prospectively examined in 45 patients with PA.
Results: Patients with PA were found to be significantly associated with severe OSA even after adjustment for other clinical risk factors (odds ratio 2.08, 95% confidence interval 1.09-3.95, p = 0.025) as compared to those without PA. Furthermore, the logarithm of the renin activity after treatment and change in AHI before and after treatment were significantly negatively correlated, with Pearson's correlation coefficient (r = -0.364, p = 0.014).
Conclusions: Severe OSA is more commonly seen in PA patients with hypertension as compared to patients without PA, and elevated renin activity may contribute to improvement of sleep apnea in patients with PA.
背景:阻塞性睡眠呼吸暂停(OSA)在原发性醛固酮增多症(PA)患者中发病率较高,而治疗后肾素活性升高与心血管事件风险降低有关。然而,PA 与 OSA 程度的关系仍不清楚,PA 患者肾素活性的升高是否与呼吸暂停状况的变化有关也不得而知。研究方法使用呼吸监测仪调查了 PA(176 人)与按呼吸暂停-低通气指数(AHI)分类的 OSA 程度之间的横断面关系,并将结果与非 PA 患者(418 人)进行了比较。此外,还对 45 名 PA 患者的肾素活性升高对 AHI 变化的影响进行了前瞻性研究:结果发现:与无 PA 患者相比,即使调整了其他临床风险因素,PA 患者仍与严重 OSA 显著相关(几率比 2.08,95% 置信区间 1.09-3.95,P = 0.025)。此外,治疗后肾素活性的对数与治疗前后 AHI 的变化呈显著负相关,皮尔逊相关系数(r = -0.364,p = 0.014):结论:与非 PA 患者相比,严重 OSA 更常见于伴有高血压的 PA 患者,而肾素活性升高可能有助于改善 PA 患者的睡眠呼吸暂停。